News | July 04, 2023
Adare Pharma divests Adare Biome to dsm-firmenich
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The transaction represents an enterprise value of €275 million, an estimated 2023 EV/EBITDA multiple of 18x
The VITA-FAST tokens have been met with overwhelming interest
Science communication brings behavioural changes
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
Proposed combination enhances Pfizer’s position as a leading company in oncology
Sonowal exhorted young researchers and scientist to work on evidence based scientific research
The Ministry of Ayush endeavour is to get entry level NABH certification for 12,500 Ayush Wellness Centers by the end of 2023
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
The newly built complex of RRIUM, which will be under CCRUM, the apex government organization for research in Unani Medicine
On the precision oncology front, expanded larotrectinib data will focus on efficacy and safety findings for pediatric and adult patients with NTRK gene fusion-positive solid tumors
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
